Planta Medica
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lyonia 7(1) 2004 - Conservation of Biological and Cultural Diversity in the Andes and the Amazon Basin - Flora and Vegetation
Lyonia 7(1) 2004 - Conservation of Biological and Cultural Diversity in the Andes and the Amazon Basin - Flora and Vegetation Volume 7(1) December 2004 ISSN: 0888-9619 odd-right: 2 Introduction Scientists widely agree that species extinction has heavily accelerated in the last decades. The majority of the worlds species are found in tropical forests, covering a mere ten percent of the planets surface. A grave problem for the conservation of diversity is the still very fragmentary knowledge of the ecology of most species. The Andes and the Amazon Basin represent one of the most important Biodiversity-Hotspots on Earth. Attempts of sustainable management and conservation must integrate local communities and their traditional knowledge. Management decisions need to include the high importance of natural resources in providing building materials, food and medicines for rural as well as urbanized communities. The traditional use of forest resources, particularly of non-timber products like medicinal plants, has deep roots not only in indigenous communities, but is practiced in a wide section of society. The use of medicinal herbs is often an economically inevitable alternative to expensive western medicine. The base knowledge of this traditional use is passed from one generation to the next. Especially the medical use represents a highly dynamic, always evolving process, where new knowledge is constantly being obtained, and linked to traditional practices. An increased emphasis is being placed en possible economic benefits especially of the medicinal use of tropical forest products instead of pure timber harvesting, an approach particularly appealing to countries with difficult economic conditions. Most research efforts, due to lack of manpower, time end resources, focus only on either biodiversity assessments or ethnobotanical inventories, or try to implement management and use measures without having a sound scientific base to do so. -
Assessment Report on Tanacetum Parthenium (L.) Schultz Bip., Herba. Draft
25 September 2019 EMA/HMPC/48716/2019 Committee on Herbal Medicinal Products (HMPC) Assessment report on Tanacetum parthenium (L.) Schultz Bip., herba Draft – Revision 1 Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Herbal substance(s) (binomial scientific name of the plant, including plant part) Tanacetum parthenium (L.) Schultz Bip., herba Herbal preparation Powdered herbal substance Pharmaceutical form(s) Herbal preparation in solid dosage forms for oral use First assessment Rapporteur G Calapai Peer-reviewer B Kroes Revision Rapporteur A Assisi Peer-reviewer B Kroes Note: This draft assessment report is published to support the public consultation of the draft European Union herbal monograph on Tanacetum parthenium (L.) Schultz Bip., herba. It is a working document, not yet edited, and shall be further developed after the release for consultation of the monograph. Interested parties are welcome to submit comments to the HMPC secretariat, which will be taken into consideration but no ‘overview of comments received during the public consultation’ will be prepared on comments that will be received on this assessment report. The publication of this draft assessment report has been agreed to facilitate the understanding by Interested Parties of the assessment that has been carried out so far and led to the preparation of the draft monograph. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2019. -
The Phytochemistry of Cherokee Aromatic Medicinal Plants
medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs. -
Shilin Yang Doctor of Philosophy
PHYTOCHEMICAL STUDIES OF ARTEMISIA ANNUA L. THESIS Presented by SHILIN YANG For the Degree of DOCTOR OF PHILOSOPHY of the UNIVERSITY OF LONDON DEPARTMENT OF PHARMACOGNOSY THE SCHOOL OF PHARMACY THE UNIVERSITY OF LONDON BRUNSWICK SQUARE, LONDON WC1N 1AX ProQuest Number: U063742 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U063742 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENT I wish to express my sincere gratitude to Professor J.D. Phillipson and Dr. M.J.O’Neill for their supervision throughout the course of studies. I would especially like to thank Dr. M.F.Roberts for her great help. I like to thank Dr. K.C.S.C.Liu and B.C.Homeyer for their great help. My sincere thanks to Mrs.J.B.Hallsworth for her help. I am very grateful to the staff of the MS Spectroscopy Unit and NMR Unit of the School of Pharmacy, and the staff of the NMR Unit, King’s College, University of London, for running the MS and NMR spectra. -
Phytochem Referenzsubstanzen
High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039. -
Bark Medicines Used in Traditional Healthcare in Kwazulu-Natal, South Africa: an Inventory
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector South African Journal of Botany 2003, 69(3): 301–363 Copyright © NISC Pty Ltd Printed in South Africa — All rights reserved SOUTH AFRICAN JOURNAL OF BOTANY ISSN 0254–6299 Bark medicines used in traditional healthcare in KwaZulu-Natal, South Africa: An inventory OM Grace1, HDV Prendergast2, AK Jäger3 and J van Staden1* 1 Research Centre for Plant Growth and Development, School of Botany and Zoology, University of Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa 2 Centre for Economic Botany, Royal Botanic Gardens, Kew, Richmond, Surrey TW9 3AE, United Kingdom 3 Department of Medicinal Chemistry, Royal Danish School of Pharmacy, 2 Universitetsparken, 2100 Copenhagen 0, Denmark * Corresponding author, e-mail: [email protected] Received 13 June 2002, accepted in revised form 14 March 2003 Bark is an important source of medicine in South Overlapping vernacular names recorded in the literature African traditional healthcare but is poorly documented. indicated that it may be unreliable in local plant identifi- From thorough surveys of the popular ethnobotanical cations. Most (43%) bark medicines were documented literature, and other less widely available sources, 174 for the treatment of internal ailments. Sixteen percent of species (spanning 108 genera and 50 families) used for species were classed in threatened conservation cate- their bark in KwaZulu-Natal, were inventoried. gories, but conservation and management data were Vernacular names, morphological and phytochemical limited or absent from a further 62%. There is a need for properties, usage and conservation data were captured research and specialist publications to address the in a database that aimed to synthesise published infor- gaps in existing knowledge of medicinal bark species mation of such species. -
Suramin Pharmacokinetics After Regional Or Systemic
TRANSLATIONAL RESEARCH IN CANCER: PRECLINICAL PHARMACODYNAMICS AND CANCER EPIDEMIOLOGY DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Jia Ji, M.A.S. Graduate Program in Pharmacy The Ohio State University 2009 Dissertation Committee: Dr. Jessie L.-S. Au, Advisor Dr. M. Guillaume Wientjes Dr. Dennis B. McKay Copyright by Jia Ji 2009 ABSTRACT Translational research bridges preclinical and clinical research and shortens distance between these two areas in biomedical research. In preclinical study, our laboratory has found suramin sensitization at low and non-toxic dose and antagonism at toxic dose in multiple experimental models. The first part of this dissertation, Chapter 2 and 3, aims to evaluate cellular pharmacodynamics (PD) of biphasic effect of suramin and identify potential PD endpoint for future application in clinical practice. In Chapter 2, we first established an in vitro experimental model that illustrated suramin sensitization and antagonism to cisplatin, known as DNA-damaging drug. Addition of low dose suramin enhanced cellular response to cisplatin-induced DNA damage in three aspects, which are cell cycle arrest, cell death and senescence. Chapter 3 documented that persistence of γH2AX, a marker of DNA damage, was sustained by the addition of low dose suramin compared with cisplatin-alone treatment. No significant change of γH2AX kinetics was detected when suramin biphasic effect to taxanes, non-DNA-damaging drugs, was observed under both in vitro and in vivo settings. These preclinical discoveries not only lead us to treatment-dependant mechanism of suramin sensitization effect, but also indicate prospective clinical application of γH2AX as PD endpoint in anti-cancer therapy combined with suramin. -
Phenylpropanoids
Phenylpropanoids The phenylpropanoids are a diverse family of organic compounds that are synthesized by plants from the amino acids phenylalanine and tyrosine. Their name is derived from the six-carbon, aromatic phenyl group and the three-carbon propene tail of cinnamic acid, which is synthesized from phenylalanine in the first step of phenylpropanoid biosynthesis. Phenylpropanoids are found throughout the plant kingdom, where they serve as essential components of a number of structural polymers, provide protection from ultraviolet light, defend against herbivores and pathogens, and mediate plant-pollinator interactions as floral pigments and scent compounds. Concentrations of phenylpropanoids within plants are also altered by changes in resource availability. www.MedChemExpress.com 1 Phenylpropanoids Inhibitors & Modulators (+)-Columbianetin (+)-Columbianetin acetate ((S)-Columbianetin) Cat. No.: HY-N0363 ((S)-Columbianetin acetate) Cat. No.: HY-N0363A (+)-Columbianetin is an isomer of Columbianetin. (S)-Columbianetin acetate is an isomer of Columbianetin is a phytoalexin associated with Columbianetin. Columbianetin is a phytoalexin celery (Apium graveolens) resistance to associated with celery (Apium graveolens) pathogens during storage. Columbianetin exhibits resistance to pathogens during storage. excellent anti-fungal and anti-inflammatory Columbianetin exhibits excellent anti-fungal and activity. anti-inflammatory activity. Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 5 mg, 10 mg, 20 mg Size: 5 mg, 10 mg, 20 mg (+)-Guaiacin (+)-Peusedanol Cat. No.: HY-N2247A Cat. No.: HY-N6063 (+)-Guaiacin is a compound extracted of the bark (+)-Peusedanol is a coumarin isolated from of Machilus wangchiana Chun. (Lauraceae). Peucedanumjaponicum. (+)-Guaiacin shows potent in vitro activities against the release of β-glucuronidase in rat polymorphonuclear leukocytes (PMNs) induced by platelet-activating factor (PAF) . -
Theranostics Characterization of Drug-Induced Human Mitochondrial ADP/ATP Carrier Inhibition
Theranostics 2021, Vol. 11, Issue 11 5077 Ivyspring International Publisher Theranostics 2021; 11(11): 5077-5091. doi: 10.7150/thno.54936 Research Paper Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition Stephany Jaiquel Baron1, Martin S. King1, Edmund R.S. Kunji1, and Tom J.J. Schirris1,2 1. Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Keith Peters Building, Hills Road, Cambridge, CB2 0XY, United Kingdom. 2. Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Corresponding authors: Prof. Dr. Edmund R.S. Kunji, MRC Mitochondrial Biology Unit, University of Cambridge, Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, United Kingdom; Phone: +44 12 232 52 850; Fax: +44 12 232 52 875; Email: [email protected]; Dr. T.J.J. Schirris, ERT, Department of Pharmacology and Toxicology, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands; Phone: +31 61 517 63 47; E-mail: [email protected] © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.10.24; Accepted: 2021.01.18; Published: 2021.03.05 Abstract An increasing number of commonly prescribed drugs are known to interfere with mitochondrial function, causing cellular toxicity, but the underlying mechanisms are largely unknown. Although often not considered, mitochondrial transport proteins form a significant class of potential mitochondrial off-targets. -
Pharmacological Activities and Biologically Active Compounds Of
Research Signpost 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India Phytochemistry: Advances in Research, 2006: 87-103 ISBN: 81-308-0034-9 Editor: Filippo Imperato Pharmacological activities and biologically active compounds 4 of Bulgarian medicinal plants Stephanie Ivancheva, Milena Nikolova and Reneta Tsvetkova Department of Applied Botany, Institute of Botany, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria Abstract Bulgarian medicinal plants, which have been studied during the last years, are reviewed. The review includes the following families: Amaryllidaceae, Asteraceae, Berberidaceae, Boraginaceae, Fabaceae, Geraniaceae, Lamiaceae, Oleaceae, Onagraceae, Scrophulariaceae, Solanaceae, Ranunculaceae, Rosaceae, Rutaceae, Valerianaceae, Zygophyllaceae. Main pharmacological properties are antiviral, antimicrobial, antioxidative, anti-inflammatory, antiseptic, spasmolytic, sedative and hypotensive. Correspondence/Reprint request: Dr. Stephanie Ivancheva, Department of Applied Botany, Institute of Botany Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. E-mail: [email protected] 88 Stephanie Ivancheva et al. Introduction Bulgaria is situated in the Balkan peninsula, South-East Europe, between 22˚ 21’ 40” and 28˚ 36’ 35” E longitude, and 41˚ 14’ 05” and 44˚ 12’ 45” N latitude, occupies the area of 110 912 km2 with elevations ranging from 0 to 2925 m and has corresponding subalpine, Mediterranean and continental climates. The relief of the country is quite diverse ranging from plains to low hills and high mountains. The climate is moderate continental to modified continental, but in southern regions reflects rather a strong Mediterranean influence. As a result of this climatic conditions the Bulgarian flora is remarkable for its diversity (3500 plant species including 600 known medicinal plants) [1]. Bulgarian Flora has become very famous for the treatment of Parkinson disease with Atropa belladonna L. -
Perú: Medio Putumayo-Algodón Medio Perú: 28 No
Perú: Medio Putumayo-Algodón Medio Perú: 28 no. Perú: Medio Putumayo-Algodón Rapid Biological and Social Inventories THE FIELD MUSEUM INFORME/REPORT NO. 28 Perú: Medio Putumayo-Algodón Nigel Pitman, Adriana Bravo, Santiago Claramunt, Corine Vriesendorp, Diana Alvira Reyes, Ashwin Ravikumar, Álvaro del Campo, Douglas F. Stotz, Tyana Wachter, Sebastian Heilpern, Benjamín Rodríguez Grández, Ana Rosa Sáenz Rodríguez y/and Richard Chase Smith editores/editors Diciembre/December 2016 Instituciones Participantes/Participating Institutions The Field Museum Instituto del Bien Proyecto Especial Binacional Común (IBC) Desarrollo Integral de la Cuenca del Río Putumayo (PEDICP) Federación de Comunidades Fundación para la Herbario Amazonense de Nativas Fronterizas del Conservación y el Desarrollo la Universidad Nacional de la Putumayo (FECONAFROPU) Sostenible (FCDS) Amazonía Peruana (AMAZ) Museo de Historia Natural de Centro de Ornitología y la Universidad Nacional Mayor Biodiversidad (CORBIDI) de San Marcos (UNMSM) RI28_01-Spanish_d2(10).indd 1 12/8/16 9:25 AM LOS INFORMES DE INVENTARIOS RÁPIDOS SON PUBLICADOS POR/ Cualquiera de las opiniones expresadas en los informes de los Inventarios RAPID INVENTORIES REPORTS ARE PUBLISHED BY: Rápidos son expresamente las de los autores y no reflejan necesariamente las de The Field Museum. / Any opinions expressed in the Rapid Inventories THE FIELD MUSEUM reports are those of the authors and do not necessarily reflect those of Science and Education The Field Museum. 1400 South Lake Shore Drive Esta publicación ha sido financiada en parte por The Gordon and Betty Chicago, Illinois 60605-2496, USA Moore Foundation y The Field Museum./ This publication has been funded in T 312.665.7430, F 312.665.7433 part by The Gordon and Betty Moore Foundation and The Field Museum. -
New Insights Into the Epigenetic Activities of Natural Compounds
New Insights into the Epigenetic Activities of Natural Compounds Melita Vidakovic, Jessica Marinello, Maija Lahtela-Kakkonen, Daumantas Matulis, Vaida Linkuvienė, Benoît Y. Michel, Ruta Navakauskienė, Michael S. Christodoulou, Danielle Passarella, Saulius Klimasauskas, et al. To cite this version: Melita Vidakovic, Jessica Marinello, Maija Lahtela-Kakkonen, Daumantas Matulis, Vaida Linkuvienė, et al.. New Insights into the Epigenetic Activities of Natural Compounds. OBM Genetics, LIDSEN Publishing Inc., 2018, 131 (8), pp.3033-41. 10.21926/obm.genet.1803029. inserm-01981397 HAL Id: inserm-01981397 https://www.hal.inserm.fr/inserm-01981397 Submitted on 15 Jan 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Open Access OBM Genetics Research Article New Insights into the Epigenetic Activities of Natural Compounds Melita Vidakovic 1, †, Jessica Marinello 2, †, Maija Lahtela-Kakkonen 3, Daumantas Matulis 4, Vaida Linkuvienė 4, Benoît Y. Michel 5, †, Ruta Navakauskienė 6, Michael S. Christodoulou 7, †, Danielle Passarella 8, Saulius Klimasauskas 9, Christophe Blanquart 10, Muriel Cuendet 11, Judit Ovadi 12, Stéphane Poulain 13, †, Fabien Fontaine-Vive 5, Alain Burger 5, Nadine Martinet 5,* 1. Department of Molecular Biology, University of Beograd, Bulevar despota Stefana 142, 11000 Beograd, Serbia; E-Mail: [email protected] 2.